At the present study, we analyzed by CellMiner that the expression level of PFKP was positively related to the drug activity of protein kinase C (PKC) inhibitor Staurosporine (S4 Table), suggesting that the expression level of PFKP could affect the drug sensitivity of breast cancer cells to PKC inhibitors. The gene discussed is PRRT2; the disease is breast carcinoma.